U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839858) titled 'A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France' on Sept. 18.
Brief Summary: The aim of this study was to assess which cytoreductive treatments are currently administered in standard practice as second-line therapy to patients with polycythemia vera (PV) in France and to find out the reasons physicians switch treatments. In addition, the research aimed to describe real-world effectiveness of second-line cytoreductive therapies and the occurrence of adverse events of special interest.
Study data were collected from the medical charts of patients wh...